LLY

916.24

+1.53%↑

JNJ

241.14

+2.6%↑

ABBV

207.34

+1.28%↑

NVS

151.08

+1.83%↑

MRK

119.67

+3.41%↑

LLY

916.24

+1.53%↑

JNJ

241.14

+2.6%↑

ABBV

207.34

+1.28%↑

NVS

151.08

+1.83%↑

MRK

119.67

+3.41%↑

LLY

916.24

+1.53%↑

JNJ

241.14

+2.6%↑

ABBV

207.34

+1.28%↑

NVS

151.08

+1.83%↑

MRK

119.67

+3.41%↑

LLY

916.24

+1.53%↑

JNJ

241.14

+2.6%↑

ABBV

207.34

+1.28%↑

NVS

151.08

+1.83%↑

MRK

119.67

+3.41%↑

LLY

916.24

+1.53%↑

JNJ

241.14

+2.6%↑

ABBV

207.34

+1.28%↑

NVS

151.08

+1.83%↑

MRK

119.67

+3.41%↑

Kodu・Aktsiate loetelu・VolitionRX Ltd

VolitionRX Ltd

Avatud

0.19 -5

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

0.18

Max

0.23

Põhinäitajad
By Trading Economics
Sissetulek	936K -5.4M
Müük	221K 627K
Kasumimarginaal	-857.414
Töötajad	75
EBITDA	1.3M -4.2M

Soovitused
By TipRanks
Soovitused	Osta
12 kuu keskmine prognoos	+1400% upside

Dividendid
By Dow Jones
Järgmine tulemuste avaldamine	30. märts 2026

Turustatistika
By TradingEconomics
Turukapital	-19M 28M
Eelmine avamishind	5.19
Eelmine sulgemishind	0.19

VolitionRX Ltd Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

24. märts 2026, 18:58 UTC

Suurimad hinnamuutused turgudel

MDA Space Shares Drop After NASA Shifts Focus to Moon's Surface and Away From Space Station

24. märts 2026, 23:48 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

24. märts 2026, 23:48 UTC

Market Talk

Nikkei May Rise on Hopes for U.S.-Iran Talks -- Market Talk

24. märts 2026, 23:33 UTC

Market Talk

Uudisväärsed sündmused

Gold Rises, Boosted by Dollar Weakness -- Market Talk

24. märts 2026, 23:16 UTC

Market Talk

Venezuelan Opposition Leader Says Oil Output Could Reach 5 Million B/D -- Market Talk

24. märts 2026, 22:40 UTC

Tulu

Shanghai Fosun Pharmaceutical: Results Supported by Higher Rev From Innovative Drugs, Overseas Business >2196.HK

24. märts 2026, 22:40 UTC

Tulu

Shanghai Fosun Pharmaceutical 2025 Net CNY3.37B Vs. Net CNY2.77B >2196.HK

24. märts 2026, 22:40 UTC

Tulu

Shanghai Fosun Pharmaceutical 2025 Rev CNY41.50B Vs. CNY40.91B >2196.HK

24. märts 2026, 21:44 UTC

Market Talk

Global Equities Roundup: Market Talk

24. märts 2026, 21:44 UTC

Market Talk

Sandfire's New Bull Excited by Kalkaroo Copper Deposit -- Market Talk

24. märts 2026, 20:59 UTC

Tulu

Medtronic PLC Cuts FY26 View To Adj EPS $5.50-Adj EPS $5.54 >MDT

24. märts 2026, 20:58 UTC

Uudisväärsed sündmused

Israel Hits Russian-Iranian Weapons Smuggling Route in the Caspian Sea -- WSJ

24. märts 2026, 20:50 UTC

Market Talk

Uudisväärsed sündmused

Energy & Utilities Roundup: Market Talk

24. märts 2026, 20:50 UTC

Market Talk

Uudisväärsed sündmused

Basic Materials Roundup: Market Talk

24. märts 2026, 20:50 UTC

Market Talk

Financial Services Roundup: Market Talk

24. märts 2026, 20:25 UTC

Tulu

This Palantir-Linked Drone Stock Was Flying Under the Radar -- Until Now -- Barrons.com

24. märts 2026, 20:15 UTC

Market Talk

Uudisväärsed sündmused

Global Commodities Roundup: Market Talk

24. märts 2026, 20:10 UTC

Market Talk

Canada Mortgage Arrears Linked to Labor Market Performance -- Market Talk

24. märts 2026, 20:10 UTC

Tulu

Worthington Enterprises 3Q Sales $378.7M >WOR

24. märts 2026, 20:10 UTC

Tulu

Worthington Enterprises 3Q Adj EPS 98c >WOR

24. märts 2026, 20:10 UTC

Tulu

Worthington Enterprises 3Q EPS 92c >WOR

24. märts 2026, 19:25 UTC

Market Talk

Uudisväärsed sündmused

Canada Needs Roughly 100 Days to Meet IEA's Oil-Stock Release -- Market Talk

24. märts 2026, 19:06 UTC

Market Talk

Uudisväärsed sündmused

Oil Futures Regain Ground As Strikes Continue in Middle East -- Market Talk

24. märts 2026, 18:51 UTC

Market Talk

Uudisväärsed sündmused

U.S. Natural Gas Settles Higher As Oil Futures Gain -- Market Talk

24. märts 2026, 18:40 UTC

Market Talk

Uudisväärsed sündmused

Global Forex and Fixed Income Roundup: Market Talk

24. märts 2026, 18:40 UTC

Market Talk

Uudisväärsed sündmused

Mideast Conflict to Hobble But Not Derail Canadian Economy -- Market Talk

24. märts 2026, 18:34 UTC

Uudisväärsed sündmused

Oil Production in the Middle East Will Take Months to Come Back, CEO says. Why $100 Oil Could Be Here to Stay. -- Barrons.com

24. märts 2026, 18:27 UTC

Market Talk

Inflation Pickup Could Keep Bank of Mexico on Hold -- Market Talk

24. märts 2026, 18:21 UTC

Market Talk

Uudisväärsed sündmused

Silver Snaps 9-Session Losing Streak -- Market Talk

24. märts 2026, 18:00 UTC

Omandamised, ülevõtmised, äriostud

Gilead to Buy Ouro Medicines for $2.2 Billion. Why the Deal Is Key to Future Stock Gains. -- Barrons.com

Võrdlus sarnastega

Hinnamuutus

VolitionRX Ltd Prognoos

Hinnasiht

By TipRanks

1400% tõus

12 kuu keskmine prognoos

Keskmine 3 USD 1400%

Kõrge 3 USD

Madal 3 USD

Põhineb 1 Wall Streeti analüütiku instrumendi VolitionRX Ltd 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

1 ratings

Osta

Hoia

Müü

Põhineb 1 analüütiku instrumendi VolitionRX Ltd aktsia reitingul - viimase 3 kuu andmed.

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

Ettevõttest VolitionRX Ltd

VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose and monitor a range of cancers, and sepsis and COVID-19 in the United States and internationally. The company offers Nu.Q Vet, a cancer screening test for dogs and other animals; Nu.Q Nets for monitoring the immune system; Nu.Q Cancer for monitoring disease progression, response to treatment and minimal residual disease; Capture-PCR, an isolating and capturing circulating tumor derived DNA from plasma samples for early cancer detection; and Nu.Q Discover, a solution to profiling nucleosomes. VolitionRx Limited is based in Henderson, Nevada.